Immunology Antibodies for Immune Cell and Inflammatory Research

Immunology antibodies are research reagents that recognize molecules involved in immune-cell identity, signaling, activation and regulation. Targets include cytokines, chemokines, receptors, immune checkpoints, immunoglobulins, complement proteins and intracellular signaling molecules. The appropriate antibody depends on the biological question, experimental species, sample type and method being used.

Begin with established lineage markers, then add markers that distinguish relevant differentiation or activation states. A single marker is often insufficient because many antigens are shared between cell types. Marker selection should reflect the tissue, species and biological context, and the final population should be supported by an appropriate gating or imaging strategy.

Only when the exact product has been validated for both methods. Flow cytometry often detects native antigens on suspended cells, while immunohistochemistry examines antigens altered by fixation and tissue processing. Differences in epitope accessibility can cause an antibody to perform well in one method but poorly in another.

A detection antibody is selected primarily for measuring or localizing a target. A neutralizing antibody is documented to inhibit a biological interaction or activity under defined conditions. An antibody that binds a cytokine or receptor does not necessarily block its function, so neutralization or blocking capability must be supported for the exact reagent.

Many immune markers are not exclusive to one lineage. Expression can overlap between related populations or change after activation, differentiation and migration into tissues. Nonspecific binding and poor gating may also contribute. Use additional lineage markers, viability controls and expected biological patterns to determine whether the signal is meaningful.

Yes. Stimulation can increase, decrease or redistribute cytokines, receptors and activation markers. Some proteins may be internalized, shed from the surface or produced only transiently. Experimental timing, secretion inhibitors and fixation conditions should therefore be standardized when comparing stimulated and unstimulated samples.

Include unstimulated and stimulated samples, a known positive response where possible and suitable vehicle or treatment controls. Flow cytometry experiments may also require unstained, single-color, viability and fluorescence-minus-one controls. Functional blocking studies should include an appropriate isotype or irrelevant antibody tested at comparable conditions.

High background may arise from Fc receptor binding, dead cells, insufficient blocking, excessive antibody concentration, incompatible secondary reagents or inadequate washing. Immune cells such as monocytes and macrophages can bind antibodies nonspecifically through Fc receptors. Fc-blocking reagents, antibody titration and careful viability gating may improve specificity.